David Pauling, Chief Administration Ofcr. & GC at SUTRO BIOPHARMA, INC. (STRO), bought 12,504 shares at $0.80 ($10K) on 2025-10-15, disclosed to the SEC on 2025-10-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.